News
Public · Published
Rosenblatt maintains Xometry at Buy, raises price target to $130 from $120
Rosenblatt maintained its Buy rating on Xometry and raised its price target to $130 from $120. The new target is an 8.3% increase and implies 16.8% upside from Xometry's November 3 closing price of $111.29.
Published:
Updated:
What happened
Rosenblatt maintained its Buy rating on Xometry and raised its price target to $130 from $120. The new target is an 8.3% increase and implies 16.8% upside from Xometry’s November 3 closing price of $111.29.
Confirmed
Global impact / market context
The higher target signals that Rosenblatt sees more potential value in Xometry shares while keeping its positive rating unchanged. A price target is an analyst’s estimate, not a guaranteed outcome; it does not itself change Xometry’s sales, costs, cash available, or business operations.
Analyst inference
This update is an analyst view rather than a company announcement or a reported change in business performance. Its stated upside compares the target with the November 3 closing price, so it describes a valuation gap at that date, not a forecast of actual returns.
Analyst inference
What to watch
- Check whether later Rosenblatt updates retain the Buy rating or revise the $130 target; either would show whether the analyst’s view has changed. Analyst inference
- Compare future company updates with the target’s assumptions, especially any reported changes in revenue, costs, or cash available; none are provided in this article. Analyst inference
- Track Xometry’s share price against the November 3 close of $111.29 and the $130 target, while recognizing that prices can move independently of analyst estimates. Analyst inference
Evidence
- Original source link unavailable